Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment
Ronald J. Bosch(Harvard University), Michelle Cespedes(Icahn School of Medicine at Mount Sinai), Xinyan Zhang(Jinzhou Central Hospital), Peter W. Hunt(University of California, San Francisco), Scott M. Hammer, Kristine B. Patterson(University of North Carolina at Chapel Hill)
Cited by 1
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k